Bio Essence Corp (BIOE) stock
BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
$0.42+0.03 (+7.72%)
Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –
Bio Essence statistics
41 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 13.0%
- 10.8%
- Shares Change (QoQ)
- 15.0%
- 0.50%
- Float
- 40M
- 49M
- Shares Held by Insiders
- 24.9%
- 11.7%
MarginsIndustry
- Pretax Margin
- 52.8%
- -11.6%
- EBITDA Margin
- 56.4%
- -27.7%
Returns on capitalIndustry
- Return on Assets (ROA)
- 73.7%
- -40.6%
- Return on Capital Employed (ROCE)
- 64.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 0.38
- 3.30
- Quick Ratio
- 0.00
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 416.6%
- 6.82%
- Revenue Growth (3Y CAGR)
- 45.1%
- 2.25%
- Revenue Growth (5Y CAGR)
- 14.6%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.41
- 0.40
- Revenue Per Employee
- $727.88K
- $429.29K
- Profits Per Employee
- $379.38K
- -$689.41K
- Employee Count
- 4
- 74
Income statement (TTM)Industry
- Pretax Income
- $1.54M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $675
- $17.76M
- Net Cash Per Share
- $0.00
- $0.80
- Equity (Book Value)
- $2.34M
- $53.89M
- Book Value Per Share
- $0.04
- $1.50
- Tangible Book Value
- -$1.05M
- $27.13M
- Working Capital
- -$998.52K
- $79.99M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- -$704
- $2.90M
- Income Tax
- $20.25K
- $73.00K
- Effective Tax Rate
- 1.32%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $0.20
- $19.34
- Piotroski F-Score
- 9
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | BIOE | S&P 500 | Difference | BIOE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +130.8% | +0.6% | +130.2 pts | ||
| 3 months | +55.6% | +3.4% | +52.2 pts | ||
| Year to date | +600.2% | +13.3% | +586.9 pts | ||
| 1 year | +511.5% | +16.6% | +494.9 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M BIOE shares were sold short on Oct 30, 2026, up 2067.5% from the previous report. At recent volumes it would take 2.1 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,738 | +2067.5% | 3,671 | 2.1 |
| Oct 15, 2026 | 357 | – | 24,404 | 1.0 |
| May 15, 2026 | 2,500 | -52.5% | 5,889 | 1.0 |
| Apr 30, 2026 | 5,262 | -36.3% | 3,614 | 1.5 |
| Apr 15, 2026 | 8,262 | +22.1% | 17,749 | 1.0 |
| Mar 31, 2026 | 6,765 | – | 16,621 | 1.0 |
| Oct 31, 2024 | 12,179 | +1559.3% | 267,698 | 1.0 |
| Oct 15, 2024 | 734 | +144.7% | 62,826 | 1.0 |
| Sep 30, 2024 | 300 | – | 57,693 | 1.0 |
| Jul 31, 2024 | 95 | +46.2% | 14,446 | 1.0 |
| Jul 15, 2024 | 65 | -89.6% | 349,774 | 1.0 |
| Jun 28, 2024 | 623 | – | 205,362 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?